|
Volumn 33, Issue 3, 2001, Pages 533-536
|
Fournier's gangrene: Can aggressive treatment save life?
a a a a a a a a a |
Author keywords
Antimicrobial therapy; Debridement; Gangrene; Genital disease; Mortality; Risk factors
|
Indexed keywords
ADULT;
AGED;
ARTICLE;
FOURNIER GANGRENE;
HUMAN;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
TESTIS DISEASE;
TREATMENT OUTCOME;
AEROBIC BACTERIUM;
ANAEROBIC BACTERIUM;
ANAMNESIS;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
BACTERIUM CULTURE;
CLINICAL FEATURE;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DEBRIDEMENT;
DECUBITUS;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
EXCISION;
HEALTH CARE COST;
HOSPITALIZATION;
HYPOPROTEINEMIA;
LIVER TOXICITY;
MIXED INFECTION;
MORTALITY;
NECROSIS;
OTOTOXICITY;
PATIENT CARE;
PLASTIC SURGERY;
REHYDRATION;
RISK FACTOR;
SERUM;
UROGENITAL TRACT DISEASE;
WOUND DRESSING;
ADULT;
AGED;
COMBINED MODALITY THERAPY;
FOURNIER GANGRENE;
HUMANS;
MALE;
MIDDLE AGED;
TESTICULAR DISEASES;
TREATMENT OUTCOME;
HUMAN;
MIDDLE AGE;
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
ANALGESIC AGENT;
ANTIBIOTIC AGENT;
ANTITOXIN;
CEPHALOSPORIN DERIVATIVE;
EFLORAN;
INSULIN;
IRUXOL;
LIVER PROTECTIVE AGENT;
MEDAZOL;
METRONIDAZOLE;
PROTEINASE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
UNCLASSIFIED DRUG;
|
EID: 0035545333
PISSN: 03011623
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1019554327341 Document Type: Article |
Times cited : (16)
|
References (14)
|